| Systematic (IUPAC) name | |
|---|---|
| 4-[2-({6-[(2-phenylethyl)amino]hexyl}amino)ethyl]benzene-1,2-diol | |
| Identifiers | |
| CAS number | 86197-47-9 |
| ATC code | C01CA14 |
| PubChem | 55483 |
| Chemical data | |
| Formula | C22H32N2O2 |
| Mol. mass | 429.43 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Dopexamine is a β2-adrenergic receptor agonist. It also acts at dopamine receptors.[1]
Use in sepsis has been proposed.[2]
It is considered a inotropic agent.[3]
References
- ^ Brown RA, Dixon J, Farmer JB, et al. (July 1985). "Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors". Br. J. Pharmacol. 85 (3): 599–608. PMID 2862944.
- ^ Birnbaum J, Klotz E, Spies CD, et al. (2006). "Effects of dopexamine on the intestinal microvascular blood flow and leukocyte activation in a sepsis model in rats". Crit Care 10 (4): R117. doi:. PMID 16893450. PMC 1750974. http://ccforum.com/content/10/4/R117.
- ^ Lisbon A (May 2003). "Dopexamine, dobutamine, and dopamine increase splanchnic blood flow: what is the evidence?". Chest 123 (5 Suppl): 460S–3S. doi:. PMID 12740229. http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=12740229.
|
|||||||||||||||||||||||||||||||||
| This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)




